ERBB2 and breast carcinoma: For example, CST1 is highly expressed in Luminal B breast cancer cells, SEMA3B is highly expressed in HER2-positive breast cancer cells, while SEMA3B stands out in the analysis of progression-free survival, and PLAT is highly expressed in basal-like breast cancer cells.